Sientra Inc. (SIEN)
Company Description
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally.
It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names.
The company also provides body contouring products; facial and nasal implants; saline filled sizers.
It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties.
The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007.
Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.

Country | United States |
IPO Date | Oct 29, 2014 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 304 |
CEO | Ronald Menezes |
Contact Details
Address: 420 South Fairview Avenue Santa Barbara, California United States | |
Website | https://sientra.com |
Stock Details
Ticker Symbol | SIEN |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001551693 |
CUSIP Number | 82621J105 |
ISIN Number | US82621J1051 |
Employer ID | 20-5551000 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Ronald Menezes | President, Chief Executive Officer & Director |
Andrew C. Schmidt | Senior Vice President, Treasurer & Chief Financial Officer |
Matt Hostetler | Chief People Officer |
Adelle Walker | Senior Vice President of Corporate Strategy & Marketing |
Caroline F. Van Hove | Executive Chair of Board of Directors |
Dr. Denise Dajles | Chief Technical Officer |
Keith J. Sullivan | Director & Advisor to MiraDry Business |
Mark S. Saxton | Senior Vice President Sales |
Oliver Christian Bennett | Senior Vice President, Chief Legal, Compliance, & Corporate Development Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 25, 2024 | 15-12G | Filing |
Jun 25, 2024 | 8-K | Current Report |
Apr 29, 2024 | 8-K | Current Report |
Apr 18, 2024 | 8-K | Current Report |
Apr 09, 2024 | 25-NSE | Filing |
Mar 29, 2024 | NT 10-K | Filing |
Feb 20, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Feb 16, 2024 | 8-K | Current Report |
Feb 13, 2024 | 8-K | Current Report |
Feb 06, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |